Oral Health Management of Patients at Risk of Medication-related Osteonecrosis of the Jaw (ONJ, MRONJ) is designed to assist and support primary care dental teams in providing appropriate care for patients prescribed anti-resorptive or anti-angiogenic drugs.

The guidance aims to support the dentist/dental team to:

• assess a patient’s individual medication-related osteonecrosis of the jaw (MRONJ) risk level;
• optimise the patient’s oral health during the initial phase of drug treatment;
• continue to provide routine dental care for this patient group in the primary care setting.